Cargando…
Correction to: Serum peptidome based biomarkers searching for monitoring minimal residual disease in adult acute lymphocytic leukemia
Autores principales: | Bai, Ju, He, Aili, Huang, Chen, Yang, Juan, Zhang, Wanggang, Wang, Jianli, Yang, Yun, Zhang, Pengyu, Zhang, Yang, Zhou, Fuling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585291/ https://www.ncbi.nlm.nih.gov/pubmed/33110398 http://dx.doi.org/10.1186/s12953-020-00166-4 |
Ejemplares similares
-
Serum peptidome based biomarkers searching for monitoring minimal residual disease in adult acute lymphocytic leukemia
por: Bai, Ju, et al.
Publicado: (2014) -
Potential biomarkers for adult acute myeloid leukemia minimal residual disease assessment searched by serum peptidome profiling
por: Bai, Ju, et al.
Publicado: (2013) -
Serum peptidomic profiling identifies a minimal residual disease detection and prognostic biomarker for patients with acute leukemia
por: SONG, WEI, et al.
Publicado: (2013) -
C59T mutation in exon 2 of monocytic leukemia-associated antigen-34 gene indicates a high risk of recurrence of acute myeloid leukemia
por: Lei, Bo, et al.
Publicado: (2017) -
Prokaryotic expression of MLAA-34 and generation of a novel human ScFv against MLAA-34 by phage display technology
por: Zhang, Yang, et al.
Publicado: (2017)